MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Clinical features and natural course of corticobasal degeneration and progressive supranuclear palsy presenting as corticobasal syndrome

    I. Aiba, M. Yoshida, T. Shimohata, Y. Hayashi, T. Sano, Y. Saito, S. Murayama, K. Hasegawa, Y. Iwasaki, M. Sakai, K. Wakabayashi, T. Komori, K. Nakashima (Nagoya, Japan)

  • Clinical Features of Depressive Disorders in Parkinson’s Disease: Possibilities of their Correction

    A. Umarov, G. Rakhimbaeva (Tashkent, Uzbekistan)

  • Clinical features of impaired communication in patients with multiple system atrophy

    T. Shimohata, M. Yamada, M. Hotta, Y. Ohno, H. Shibata, M. Yasunishi, Y. Suzuki, Y. Hayashi, A. Kimura (Aichi, Japan)

  • Clinical Implication of Stimulus Induced Dyskinesia in Pallidal Deep Brain Stimulation for Advanced Parkinson’s Disease

    S.H Lee, K.W Park, S.Y Jo, Y.S Hwang, M.S Kim, S.R Jeon, S.J Chung (Seoul, Republic of Korea)

  • Clinical outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency (PTPSd)

    F. Nardecchia, F. Manti, S. Galosi, A. Burlina, D. Gueraldi, M. Donati, F. Pochiero, a. Cassio, F. Porta, M. Spada, C. Carducci, C. Carducci, S. Paci, G. Banderali, M. Schiaffino, N. Blau, V. Leuzzi (Rome, Italy)

  • Clinical outcomes after DBS surgery in cognitively impaired patients with PD

    M. Patel, E. Staikova, D. Loring, M. DeLong, S. Triche, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, C. Buetefisch, S. Miocinovic (Atlanta, GA, USA)

  • Clinical profile and cerebral metabolic characteristic of cognitive impairments in multiple system atrophy

    C. Shen, F.T Liu, JJ. Ge, P. Wu, C.T Zuo, J. Wang (Shanghai, China)

  • Clinical progression of Parkinson’s disease: insights from the NINDS common data elements

    M. Lewis, E. Harkins, E. Lee, C. Stetter, B. Snyder, T. Corson, G. Du, L. Kong, X. Huang (Hershey, PA, USA)

  • Clinical research of serum uric acid levels in Parkinson’s disease

    J.W Wu, T. Wang (Wuhan, China)

  • Clinician Ratings of Cognition Predict Trajectory of Cognitive Decline in Newly Diagnosed Individuals with Parkinson’s disease

    F. Lopez, E. Trifilio, A. Ratajska, L. Kenney, D. Bowers (Gainesville, FL, USA)

  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley